Recently, in HCT-8R—a TP53 wild type CRC cell line insensitive to 5-FU—the suppression of the checkpoint kinase 1 (CHK1) pathway, induced by WNT/β-catenin activation, has been described as a potential mechanism associated to the acquired resistance to chemotherapy drugs. The gene discussed is TP53; the disease is colorectal carcinoma.